PMID: 16617229Apr 18, 2006Paper

Results of an 8-week, outpatient pulmonary rehabilitation program on patients with and without chronic obstructive pulmonary disease

Journal of Cardiopulmonary Rehabilitation
Gregory FerreiraPeter Spiegler

Abstract

To determine whether there is any difference in the effect of pulmonary rehabilitation (PR) on outcomes in patients with and without chronic obstructive pulmonary disease (COPD). Retrospective analysis of medical records of all patients enrolling in PR over a 5-year period. A total of 422 patients enrolled in a multidisciplinary PR program from August 1999 to April 2004. Three hundred nine patients had COPD and 113 patients had diagnoses other than COPD. Three hundred seventy-nine patients completed the program. PR was conducted according to currently accepted guidelines. Measurements included the 6-minute walk distance (6MW) performed at the beginning and end of the program and quality of life as determined by the Chronic Respiratory Questionnaire (CRQ) at the beginning and end of the program. Both groups had significant improvements in the 6MW and all domains of the CRQ following PR. There was no significant difference in any of these outcomes between the 2 groups. The baseline forced expiratory volume in 1 second (FEV1) was not correlated with improvement in the 6MW in either group. There is no significant difference in improvement in exercise tolerance or quality of life following PR in COPD versus non-COPD patients. Baseli...Continue Reading

References

Mar 1, 1990·The American Review of Respiratory Disease·S Foster, H M Thomas
Dec 1, 1989·Controlled Clinical Trials·R JaeschkeG H Guyatt
May 29, 1982·British Medical Journal·R J ButlandD M Geddes
Nov 19, 1994·Lancet·R S GoldsteinG H Guyatt
Apr 1, 1997·American Journal of Respiratory and Critical Care Medicine·D A RedelmeierG H Guyatt
Dec 31, 2002·American Journal of Respiratory and Critical Care Medicine·Andrew L RiesLela M Prewitt

❮ Previous
Next ❯

Citations

Jun 27, 2007·Journal of Palliative Medicine·Graeme M RockerPaul Hernandez
Jan 19, 2008·American Journal of Respiratory and Critical Care Medicine·Eileen G CollinsFranco Laghi
Apr 8, 2011·American Journal of Respiratory and Critical Care Medicine·Ganesh RaghuUNKNOWN ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis
Jun 30, 2009·The Tohoku Journal of Experimental Medicine·Hitoshi KagayaTakanobu Shioya
Nov 17, 2010·International Journal of Behavioral Medicine·Maarten J FischerAdrian A Kaptein
Jul 8, 2010·Chest·Christopher J RyersonHarold R Collard
May 31, 2014·Clinics in Chest Medicine·Carolyn L RochesterRebecca H Crouch
Jan 31, 2012·Journal of Pain and Symptom Management·Christopher J RyersonHarold R Collard
Jun 21, 2016·Archives of Physical Medicine and Rehabilitation·Annemarie L LeeAnne E Holland
Feb 23, 2011·Chronic Respiratory Disease·H K OngL Denehy
Jun 3, 2010·Respiration; International Review of Thoracic Diseases·Ryo KozuShigeru Kohno
Apr 9, 2010·Current Opinion in Supportive and Palliative Care·Christopher J RyersonSteven Z Pantilat
Nov 21, 2013·BMC Medicine·Eui-Sik SuhNicholas Hart
Oct 15, 2014·Journal of Cardiopulmonary Rehabilitation and Prevention·Randall E KeyserLeighton Chan
Jul 21, 2017·Journal of Cardiopulmonary Rehabilitation and Prevention·Lam-Phuong NguyenKimberly Hardin
Feb 14, 2013·Journal of Cardiopulmonary Rehabilitation and Prevention·Lisa WickersonDina Brooks
Dec 31, 2009·Journal of Cardiopulmonary Rehabilitation and Prevention·Chris Garvey
Feb 23, 2012·Journal of Cardiopulmonary Rehabilitation and Prevention·Uta OchmannDennis Nowak
Jul 31, 2021·Annals of Physical and Rehabilitation Medicine·Sara Souto-MirandaAlda Marques

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.